Effects of speleotherapy in Çankırı Salt Cave and haloaeresoltherapy in the salt chamber on COPD and bronchial asthma patients: a preliminary experimental pilot study
Current Research in Health Sciences · 2026
DOI: 10.62425/crihs.1854131 ↗Abstract
AbstractObjective: The study was conducted to evaluate the effects of speleotherapy in the Çankırı Salt Cave and haloaerosol therapy in a salt room on patients with Chronic Obstructive Pulmonary Disease (COPD) and bronchial asthma. Methods: The study was conducted with a total of 33 individuals, who received speleotherapy in the cave per day for 15 days and also received haloaerosol therapy in an artificial salt chamber per day. Participants were tested before and after the intervention with Medical Research Council (mMRC) Dyspnea Scale, COPD Assessment Test (CAT), SF-12 Quality of Life Scale (SF-12 QoL), Six-Minute Walk Test (6MWT), Borg Dyspnea Scale (BDS), Pulmonary Function Tests (Spirometry), BODE Index. Significance levels before and after the intervention were determined using nonparametric tests based on test means. Results: The mMRC dyspnea scale, CAT, BODE index scores showed a significant decrease after the intervention compared to baseline. Scores of the SF-12 QoL scale increased significantly following the intervention. In the 6MWT, the walking distance significantly increased after the intervention. Conclusion: The combination of speleotherapy and haloaerosoltherapy in COPD and asthmatic bronchitis patients improved breathing, reduced disease symptoms, increased exercise capacity and improved quality of life.
EUVIMED